HUM earnings call for the period ending September 30, 2020.
News & Analysis: Humana
Being an easy target, uncertainty, and a declining industry give these three stocks plenty to worry about.
Livongo is making a big splash in telemedicine, especially given its upcoming merger with Teladoc, but Humana is a better alternative for investors.
There's a possibility we may not get a coronavirus vaccine through clinical trials. Here are three stocks to buy in case that happens.
The insurer will use the tech company's product to help power its new care management platform.
HUM earnings call for the period ending June 30, 2020.
Insurance companies know how to play it safe. These three big players in healthcare all offer nice income.
Teladoc is hot right now, but bigger players are in a better position to benefit from the rise of telehealth.
Solid first-quarter earnings results and steady forward guidance helped these healthcare stocks surge last month.
HUM earnings call for the period ending March 31, 2020.